Skip to main content
    E

    Eocene Ltd. (EOCN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.75
    -0.45 (-20.40%)

    Market Cap: $2.63M

    Last updated: Nov 20, 2026 at 11:38 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    75%(3/4)
    Avg Surprise
    -2.37%
    Streak
    2 Q

    Upcoming Estimates

    Reports Nov 24, 2026 (est.)Period ending Sep 30, 2026
    EPS Consensus-$3.06
    Range-$3.06 - -$3.06
    1 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$3.12+1.9%
    60d ago-$3.12+1.9%
    30d ago-$3.12+1.9%
    7d ago-$3.12+1.9%
    Current-$3.06
    Revenue Consensus
    N/A
    RangeN/A
    1 analysts
    Last 12 of 38 reported quarters and 1 upcoming estimate
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Sep 26EST
    Exp. Nov 24
    --$3.06-$3.06 - -$3.06--1
    1
    0
    30d
    -
    Jun 26
    Reported Aug 31
    -$2.86-$3.12N/A+8.33%Beat--+43.4%
    Mar 26
    Reported May 20
    -$2.32-$3.04N/A+23.68%Beat--+53.3%
    Dec 25
    Reported Dec 31
    -$7.36-$4.08N/A-80.39%Miss--+52.3%
    Sep 25
    Reported Nov 26
    -$2.64-$4.32N/A+38.89%Beat--+85.7%
    Jun 25
    Reported Aug 28
    -$5.06N/AN/A----+70.4%
    Mar 25
    Reported May 22
    -$4.96N/AN/A----+77.9%
    Dec 24
    Reported Mar 26
    -$15.42N/AN/A----+59.8%
    Sep 24
    Reported Nov 29
    -$18.46N/AN/A----+18.5%
    Jun 24
    Reported Aug 1
    -$17.07N/AN/A----+81.2%
    Mar 24
    Reported May 8
    -$22.41N/AN/A----+78.6%
    Dec 23
    Reported Mar 14
    -$38.36N/AN/A----+74.6%
    Sep 23
    Reported Nov 6
    -$22.64N/AN/A----+92.6%

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-0.03xFCF Yield-3899.94%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-68.20%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio4.16xQuick Ratio4.16x
    Trading Statistics
    Beta0.72Avg Volume9.78K
    52-Week High$9.6852-Week Low$2.05

    Technical Indicators Dashboard

    As of Nov 19, 2026, the price is 44.0% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 23.8, below 30, the oversold line.

    Moving Averages

    SMA 10$2.45
    SMA 20$2.71
    SMA 50$3.12
    SMA 200$4.34
    EMA 10$2.38
    EMA 20$2.62
    EMA 50$3.09
    EMA 200$4.68

    MACD

    Line: -0.29Signal: -0.23Hist: -0.06

    ADX

    ADX: 37.5+DI: 8.5-DI: 33.9

    Aroon & PSAR

    Aroon Up40.0
    Aroon Down100.0
    PSAR$3.10

    Bollinger Bands

    Upper Band$3.46
    Lower Band$1.96
    %B Position5548%(Upper)
    Band Width-0.14

    RSI (14-Day)

    Oversold
    23.8

    Momentum Oscillators

    Stoch %K13.3
    Stoch %D22.8
    Williams %R-100.0
    ROC (10d)-28.6%
    Momentum-0.70
    CCI (20d)-164.1
    MFI (14d)13.5

    Volatility Measures

    ATR (14d)$0.35(20.3%)
    StdDev (20d)0.38
    Hist Vol109.1%(High)

    Volume Flow

    VWAP$1.94
    OBV290.0M
    AD Line18.8B
    CMF (20d)-0.156

    Volume Metrics

    Avg Vol (20d)10.1K
    Vol Ratio4.0x(High)
    VWMA (20d)$2.45

    Pivot Points

    R3$2.72
    R2$2.58
    R1$2.39
    Pivot Point$2.24
    S1$2.05
    S2$1.91
    S3$1.72

    Advanced Oscillators

    TSI-33.42
    Ultimate Osc49.8
    KST-228.38

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about EOCN

    News

    EOCN Valuation

    P/FCF
    -0.0x
    P/B
    0.0x
    All EOCN metrics

    EOCN Profitability: Margins, ROIC and FCF

    Eocene (EOCN) has an operating margin of 0.0% and a net margin of 0.0%.

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -68.2%
    FCF yield
    -3899.9%
    EOCN financial statements

    Eocene Competitors

    Peers by sector and size for Eocene (EOCN) include Vivos Therapeutics, Neurosense Therapeutics and Ernexa Therapeutics.

    Sector: Healthcare

    EOCN Earnings: Beat Rate and Next Report

    Eocene (EOCN) beat the EPS estimate in 3 of the last 4 quarters (75.0%). Its next report is expected on Nov 24, 2026.

    Beat rate
    3 of 4 quarters (75.0%)
    Average surprise
    -2.4%
    EPS estimate (fiscal period ending Sep 30, 2026)
    -$3.06
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 0 down

    EOCN Earnings Date

    EOCN reports Nov 24, 2026. The date is estimated.

    Updated Oct 7, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About EOCN

    When does EOCN report earnings?

    Eocene Ltd. (EOCN) is expected to report earnings on Nov 24, 2026.

    Does EOCN pay dividends?

    Eocene Ltd. (EOCN) does not currently pay a regular dividend.

    What is EOCN's market cap?

    Eocene Ltd. (EOCN) has a market capitalization of $2.63M with a current stock price of $1.75.

    Did EOCN beat earnings estimates last quarter?

    Yes. Eocene Ltd. (EOCN) reported EPS of -$2.86 for the quarter ended Jun 30, 2026, above the -$3.12 estimate, a 8.3% surprise.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.